TriNetX

27 articles with TriNetX

• TriNetX Named Technology Partner for FDA Sentinel System

  10/7/2019

  TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), has been named a technology partner in two coordinating centers of the FDA's Sentinel System, a national program that uses electronic health care data to monitor the safety of FDA-regulated drugs and other medical products.

• East Lancashire Hospitals NHS Trust Joins TriNetX to Improve Research Capabilities and Attract More Clinical Trial Opportunities

  9/12/2019

  East Lancashire Hospitals NHS Trust, a large integrated healthcare organization serving over a half million patients in north west England, has joined the TriNetX global health research network to improve its research intelligence capabilities, bring more research opportunities to its patients, and enhance overall study performance for sponsors.

• Raleigh Neurology Associates Brings Specialty Clinical Data Set to the TriNetX Research Network

  7/23/2019

  Raleigh Neurology Associates, one of the largest private neurology practices in the U.S, has joined the TriNetX global health research network adding a significant new clinical data set to the world's largest research network.

• TriNetX Applauds House Appropriations Committee for Supporting Use of Real-World Evidence in House Agriculture-FDA Spending Bill

  6/13/2019

  Praised the House Appropriations Committee for approving its fiscal year 2020 Agriculture, Rural Development, FDA, and Related Agencies bill which includes support for the use of RWE in regulatory decision making.

• TriNetX to Present at ISPOR 2019 on the Power of Real-World Data to Impact Research Across a Wide Variety of Therapeutic Areas

  5/6/2019

  TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present eight posters at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 annual meeting to be held May 18-22 in New Orleans, Louisiana.

• Hungary's University of Debrecen Joins TriNetX Network to Increase Collaboration and Growth in Commercial Clinical Studies

  4/30/2019

  The University of Debrecen has joined the TriNetX global health research network to develop collaborative research partnerships with other healthcare organizations, improve visibility to pharmaceutical companies and contract research organizations conducting clinical trials and deliver greater access to clinical research opportunities to patients.

• TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

  4/18/2019

  TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that the Journal of Clinical Hypertension has published its article on an analysis of first line treatment of essential hypertension using real-world data (RWD)

• TriNetX Secures $40 Million in Series D Funding

  3/13/2019

  Company to Accelerate International Expansion and Further Investments in AI, Machine Learning, and Digital Clinical Trials

• TriNetX Unveils Intuitive and Scalable Treatment Pathways Analytic Powered by Its Global Network of Longitudinal Real-World Data

  2/19/2019

  TriNetX announced the release of its Treatment Pathways analytic, the latest self-service capability enhancing and simplifying the analysis of real-world data.

• University Hospitals Cleveland Medical Center Leverages TriNetX to Assess Study Feasibility & Foster Research Collaborations

  1/7/2019

  University Hospitals (UH) Cleveland Medical Center, a 1,032-bed, tertiary medical center in Northern Ohio, has joined the TriNetX global health research network

• TriNetX Real-World Evidence Platform Validates Outcomes of Randomized Clinical Trials

  12/18/2018

  TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence (RWE), today announced the results of a study confirming that the TriNetX platform successfully leverages real-world data (RWD) to generate RWE to replicate results from randomized clinical trials (RCTs).

• TriNetX Announces New Capability to Streamline Propensity Score Matching

  11/12/2018

  TriNetX today announced new functionality that simplifies the way researchers conduct propensity score matching.

• TriNetX Adds Ambulatory Care, Medical & Pharmacy Claims Data to Real-World Data Platform

  11/12/2018

  Harmonized and Integrated with Highly Intuitive Analytics for Use in Designing Protocols and Conducting Observational Research

• Allergan Joins TriNetX to Access Network of Real-World Data for Clinical Research

  10/10/2018

  Allergan, a leading global pharmaceutical company, has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility, cohort analysis and site identification.

• Hadassah Medical Center Joins TriNetX to Increase Clinical Trial Collaboration Efforts with Pharma

  7/31/2018

  Hadassah Medical Center to join the TriNetX global health research network to increase clinical trial activity and help pharmaceutical companies improve the protocol design and feasibility process.

• Cardiovascular Research Consortium to Provide Access to Real-World Heart Care Data via the TriNetX Platform

  6/12/2018

  The Cardiovascular Research Consortium (CRC) has selected TriNetX's real-world evidence platform to provide the biopharmaceutical industry with the first-of-its-kind access to extensive cardiology-specific clinical data.

• Tartu University Hospital Expanding Clinical Trial Capabilities Internationally with TriNetX

  6/4/2018

  Tartu University Hospital has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally.

• TriNetX Unveils State-of-the-Art Analytics Solutions for Use with Its Clinical Data

  5/21/2018

  Enables Researchers to Hypothesize and Answer Complex Research Questions About Patient Outcomes & Treatment Effectiveness

• Pfizer Joins the TriNetX Global Health Research Network Formed to Improve Clinical Trial Design and Accelerate the Development of New Drugs

  4/10/2018

  Pfizer will have access to clinical data from TriNetX's network of healthcare organizations to support clinical study and protocol design, site identification, and patient recruitment for clinical trials across a range of therapeutic areas and development stages.

• Weill Cornell Medicine Joins TriNetX Health Research Network to Expand Breadth of Clinical Research

  1/30/2018

  TriNetX is a network comprised of healthcare organizations representing nearly 100 million patients globally, biopharmaceutical companies, and CROs.